The impact of the 340B Drug Pricing Program on Critical Access Hospitals: Evidence from Medicare Part B
10.1016/j.jhealeco.2023.102754
Saved in:
Main Author: | Han, Dan |
---|---|
Other Authors: | DEAN'S OFFICE (LKY SCH OF PUBLIC POLICY) |
Format: | Article |
Language: | English |
Published: |
ELSEVIER
2023
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/242537 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
The consequences of a public health insurance option: Evidence from Medicare Part D
by: MILLER, Daniel P., et al.
Published: (2019) -
The effects of physician retirement on patient outcomes: Anticipation and disruption
by: ZHANG, Xuan
Published: (2022) -
Estimates of national health care expenditures associated with disability
by: Anderson, W.L., et al.
Published: (2016) -
Determinants of and inequity in household expenditure on health care in Thailand
by: Woottipong Satayavongthip
Published: (2023) -
ASSOCIATION BETWEEN ACCESS TO HEALTH-PROMOTING FACILITIES AND PARTICIPATION IN CARDIOVASCULAR DISEASE (CVD) RISK SCREENING AMONG POPULATIONS WITH LOW SOCIOECONOMIC STATUS (SES) IN SINGAPORE
by: Lim, KK, et al.
Published: (2019)